Genesis Healthcare, Inc. (NYSE:GEN) Files An 8-K Submission of Matters to a Vote of Security Holders
Item 5.07Submission of Matters to a Vote of Security Holders.
The 2017 Annual Meeting of Stockholders (the Annual Meeting) of
Genesis Healthcare, Inc., a Delaware corporation (the Company),
was held on June 7, 2017. At the Annual Meeting, the Companys
stockholders voted on fiveproposals, as described below. Each of
the proposals was described in detail in the Company’s
definitive proxy statement on Schedule 14A filed with the U.S.
Securities and Exchange Commission on April 28, 2017. At the
close of business on April 10, 2017 (the record date for voting
at the Annual Meeting), there were 154,532,071 shares of the
Companys stock outstanding and entitled to vote (77,236,610
shares of the Companys Class A common stock, 15,495,019 shares of
the Companys Class B common stock and 61,800,511 shares of the
Companys Class C common). The vote totals noted below are final
voting results.
Proposal 1
The Companys stockholders elected three Class III directors, with
each to serve a three-year term expiring at the Companys 2020
Annual Meeting of Stockholders and until their successors are
duly elected and qualified, or until their earlier resignation or
removal. There were no abstentions for Proposal 1.
|
Name |
Votes For |
Votes Withheld |
Broker Non-Votes |
|
James H. Bloem |
111,905,954 |
1,445,070 |
22,028,707 |
|
John F. DePodesta |
111,853,445 |
1,497,579 |
22,028,707 |
|
Terry Allison Rappuhn |
112,035,787 |
1,315,237 |
22,028,707 |
Proposal 2
The Companys stockholders approved, on an advisory basis, the
compensation of the Companys named executive officers, as
follows:
|
Votes For |
Votes Against |
Abstentions |
Broker Non-Votes |
|
111,497,198 |
1,633,909 |
219,917 |
22,028,707 |
Proposal 3
The Companys stockholders approved, on an advisory basis, to
recommend that the advisory vote on Named Executive Officer
compensation be held every year, as follows:
|
One Year |
Two Years |
Three Years |
Abstentions |
|
110,868,478 |
95,440 |
2,337,986 |
49,120 |
Proposal 4
The Companys stockholders ratified the selection of KPMG LLP as
the Companys independent registered public accounting firm for
the fiscal year ending December 31, 2017, as follows:
|
Votes For |
Votes Against |
Abstentions |
|
134,159,535 |
52,807 |
1,167,389 |
1
Proposal 5
The Companys stockholders approved the Amended and Restated
Genesis Healthcare, Inc. 2015 Omnibus Equity Incentive Plan, as
follows:
|
Votes For |
Votes Against |
Abstentions |
Broker Non-Votes |
|
109,770,361 |
3,361,011 |
219,652 |
22,028,707 |
2
About Genesis Healthcare, Inc. (NYSE:GEN)
Genesis Healthcare, Inc., formerly Skilled Healthcare Group, Inc., is a holding company that provides post-acute care. The Company operates through three segments: inpatient services, which includes the operation of skilled nursing facilities and assisted or senior living facilities; rehabilitation therapy services, which includes its integrated and third-party rehabilitation and respiratory therapy services, and all other services, including physician services and other healthcare related services. It offers inpatient services through its network of over 500 skilled nursing and assisted/senior living facilities in 34 states, consisting of over 475 skilled nursing facilities and over 35 stand-alone assisted/senior living facilities. Its skilled nursing and assisted/senior living facilities have over 61,000 licensed beds, with its states of operation in California, Maryland, Massachusetts, New Jersey, and Pennsylvania.
